SearchStrings |
1 | 4986 | 71.55 | &esrc=s |
2 | 136 | 1.95 | tropical journal of pharmaceutical resea... |
3 | 65 | 0.93 | tjpr |
4 | 23 | 0.33 | http://www.tjpr.org/vol12_no5/2013_12_5_... |
5 | 21 | 0.30 | 1 |
6 | 17 | 0.24 | nettle(urtica dioica)+prostate |
7 | 17 | 0.24 | pharmaceutical validation |
8 | 16 | 0.23 | foeniculum vulgare fennel filetype:pdf 2... |
9 | 14 | 0.20 | range of molecular weight chitosan+low+... |
10 | 14 | 0.20 | normal c 3 level low c4 normal sle |
11 | 13 | 0.19 | liquification test of suppositories |
12 | 12 | 0.17 | tropical journal of |
13 | 12 | 0.17 | 99350103 |
14 | 11 | 0.16 | questionnaire for pharmaceutical care |
15 | 10 | 0.14 | cyp2d6 |
16 | 10 | 0.14 | albumin in hcv infection pdf reader |
17 | 10 | 0.14 | http://www.tjpr.org/vol6_no4/647prakash.... |
18 | 10 | 0.14 | tropical journal |
19 | 10 | 0.14 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
20 | 9 | 0.13 | ayurvedic ,extracts,anti‐angiogenic |
21 | 8 | 0.11 | antidiabetic activity of plant boerhaavi... |
22 | 8 | 0.11 | vial bernasconi, a-c., e. doelker & p. b... |
23 | 8 | 0.11 | nainar at al.biopharmaceutical classific... |
24 | 7 | 0.10 | cache:http://www.tjpr.org/?q=cache:http:... |
25 | 7 | 0.10 | http://www.tjpr.org/vol1%20no2/okhamafe1... |
26 | 7 | 0.10 | cache:http://www.tjpr.org/vol10_no6/2011... |
27 | 7 | 0.10 | pdf antimicrobial activities of palm ker... |
28 | 7 | 0.10 | biopharmaceutical classification system |
29 | 7 | 0.10 | cache:http://www.tjpr.org/vol8_no2/2009_... |
30 | 7 | 0.10 | nanotechnology and drug delivery |
31 | 7 | 0.10 | granisetron polyisobutylene |
32 | 7 | 0.10 | mucoadhesive drug delivery |
33 | 7 | 0.10 | tropical journal of pharmaceutical scien... |
34 | 7 | 0.10 | filetype:pdf randomised clinical trial: ... |
35 | 7 | 0.10 | controlled release drug delivery system ... |
36 | 7 | 0.10 | association of biochemical markers with ... |
37 | 7 | 0.10 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
38 | 7 | 0.10 | test for flavonoids |
39 | 6 | 0.09 | disolved orally tablet |
40 | 6 | 0.09 | low c4 but normal c3 |
41 | 6 | 0.09 | &si=cnhaloop47gcfym34godn34ada |
42 | 6 | 0.09 | used of chitosan polymer in transdermal ... |
43 | 6 | 0.09 | amino acid profile of plant leaf |
44 | 6 | 0.09 | piper crocatum |
45 | 6 | 0.09 | http://tjpr.org/ |
46 | 6 | 0.09 | microsponges composition |
47 | 6 | 0.09 | chitosan polymer filetype:pdf |
48 | 6 | 0.09 | spectrophotometric determination of furo... |
49 | 6 | 0.09 | allintext: surfactant and cosurfactant "... |
50 | 6 | 0.09 | microsphere formulation used in asthma |
51 | 6 | 0.09 | ethno pharmacological examples |
52 | 5 | 0.07 | disintegrants and flowability of powder |
53 | 5 | 0.07 | solubility of poorly water soluble drugs... |
54 | 5 | 0.07 | tropical journal of |
55 | 5 | 0.07 | evaluation and stability of chloroquine ... |
56 | 5 | 0.07 | ether extract pdf |
57 | 5 | 0.07 | tropical journal of pharmaceutical resea... |
58 | 5 | 0.07 | trop j pharm res |
59 | 5 | 0.07 | formulation and evaluation of mouth diss... |
60 | 5 | 0.07 | ethnobotany pdf |
61 | 5 | 0.07 | tropical journal of pharmacetical res |
62 | 4 | 0.06 | avicel 101 as a binder, journal |
63 | 4 | 0.06 | permeation enhancers |
64 | 4 | 0.06 | sodium starch glycolate dsc |
65 | 4 | 0.06 | effect nissl pdf |
66 | 4 | 0.06 | content |
67 | 4 | 0.06 | sultan ayesh mohammed saghir |
68 | 4 | 0.06 | cache:http://www.tjpr.org/vol10_no6/2011... |
69 | 4 | 0.06 | controlled release tablets depend on |
70 | 4 | 0.06 | drug delivery+pdf |
71 | 4 | 0.06 | normal c3 complement and a high c4 compl... |
72 | 4 | 0.06 | hygrophila spinosa |
73 | 4 | 0.06 | causative agents of uninary tract infec... |
74 | 4 | 0.06 | in process quality control tests for pha... |
75 | 4 | 0.06 | formulation and evaluation of antihypert... |
76 | 4 | 0.06 | tropical journal of pharmaceutical resea... |
77 | 4 | 0.06 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
78 | 4 | 0.06 | &ptb=8d5e23ed-f601-4326-a5ce-49abaacfb12... |
79 | 4 | 0.06 | antibiotic resistant commensal bacteria ... |
80 | 4 | 0.06 | supporitires formulation pdf |
81 | 4 | 0.06 | betahistine mesilate hplc assay |
82 | 4 | 0.06 | proniosome based transdermal delivery of... |
83 | 4 | 0.06 | higuchi, t.; connors, k. a. phase solub... |
84 | 4 | 0.06 | where can i get quinupristin inj in nige... |
85 | 3 | 0.04 | antidiarrheal activity of plants |
86 | 3 | 0.04 | diagram of bitter kola plant |
87 | 3 | 0.04 | 9c79d615d9c046a82abe9b7c5f7a9c |
88 | 3 | 0.04 | literature review on antimicrobial activ... |
89 | 3 | 0.04 | adherence hypertension primary care sett... |
90 | 3 | 0.04 | studies on wound healing properties of q... |
91 | 3 | 0.04 | brucellosis complications |
92 | 3 | 0.04 | nigeria pharmaceutical journal |
93 | 3 | 0.04 | role of ipqa in solid dosage forms |
94 | 3 | 0.04 | pdf file on bitter cola |
95 | 3 | 0.04 | stability testing of chloroquin phospha... |
96 | 3 | 0.04 | complication of brucellosis in humans |
97 | 3 | 0.04 | tropical journal |
98 | 3 | 0.04 | antidiarrheal activity of medicinal plan... |
99 | 3 | 0.04 | transdermal delivery filetype:pdf |
100 | 3 | 0.04 | phytochemical analysis in gloriosa super... |
101 | 3 | 0.04 | www.tjpr.org |
102 | 3 | 0.04 | isoniazid schiff bases antimicrobial act... |
103 | 3 | 0.04 | formulation and evaluation of tramadol h... |
104 | 3 | 0.04 | drugs to be formulated in ointment pdf |
105 | 3 | 0.04 | hunteria umbellata, medicinal uses of... |
106 | 3 | 0.04 | literature view for phytochemical screen... |
107 | 3 | 0.04 | installerex twitter?q=installerex twitte... |
108 | 3 | 0.04 | carissa carandas pdf |
109 | 3 | 0.04 | mitrascarpous scabber |
110 | 3 | 0.04 | dapi+extract+pdf |
111 | 3 | 0.04 | rapidly disintegrating tablets |
112 | 3 | 0.04 | alcoholic extract+rat+pdf |
113 | 3 | 0.04 | boswellia in dmso |
114 | 3 | 0.04 | assay of chloroquine phosphate tablet us... |
115 | 3 | 0.04 | process validation pdf |
116 | 3 | 0.04 | transdermal dmso |
117 | 3 | 0.04 | maqnufacturing technique of oral drug st... |
118 | 3 | 0.04 | anticancer:pdf |
119 | 3 | 0.04 | viruses microcapsules |
120 | 3 | 0.04 | tropical journal of pharmaceutical resea... |
121 | 3 | 0.04 | pyrazoline.pdf |
122 | 3 | 0.04 | mulberry |
123 | 3 | 0.04 | patients-perceived barriers to antiretr... |
124 | 3 | 0.04 | pafer anti fungal candida+2007+pdf |
125 | 3 | 0.04 | filetype:pdf cholestrol reduction comple... |
126 | 3 | 0.04 | validation in pharmaceutical industry |
127 | 3 | 0.04 | what is validation in pharma |
128 | 3 | 0.04 | toothpaste formulation |
129 | 3 | 0.04 | miyazaki k, islam n. nanotechnology syst... |
130 | 3 | 0.04 | herbal medicines in nigeria; images |
131 | 3 | 0.04 | http://www.tjpr.org/vol1%20no2/editorial... |
132 | 3 | 0.04 | nanotechnology in drug delivery |
133 | 3 | 0.04 | http://www.tjpr.org/vol6_no3/638sharma.p... |
134 | 3 | 0.04 | chemical substance neurology filetype:pd... |
135 | 3 | 0.04 | tropical journal of pharmaceutical resea... |
136 | 3 | 0.04 | kola pdf |
137 | 2 | 0.03 | milk analysis in nigeria |
138 | 2 | 0.03 | evaluative studies of tramadol |
139 | 2 | 0.03 | rp-hplc stability indicating method for ... |
140 | 2 | 0.03 | patient satisfaction with pharmaseutical... |
141 | 2 | 0.03 | formulation of odt |
142 | 2 | 0.03 | how does a lipid soluble drug reach the ... |
143 | 2 | 0.03 | how to increase oxygen to retina |
144 | 2 | 0.03 | odt disintegratiion timr |
145 | 2 | 0.03 | nelson a ochekpe1 |
146 | 2 | 0.03 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
147 | 2 | 0.03 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
148 | 2 | 0.03 | umar farooq state key laboratory of food... |
149 | 2 | 0.03 | oximes in op position |
150 | 2 | 0.03 | departamento de 4ciencias químico biol... |
151 | 2 | 0.03 | an overview on validation |
152 | 2 | 0.03 | synthesis of nano particle from unteria ... |
153 | 2 | 0.03 | antimicrobial effect of garcinia kola pd... |
154 | 2 | 0.03 | urtica dioica induces cytotoxicity in hu... |
155 | 2 | 0.03 | suppositories pdf |
156 | 2 | 0.03 | international medical university malaysi... |
157 | 2 | 0.03 | drug reaction in malaria patients pdf |
158 | 2 | 0.03 | study of the validation of process param... |
159 | 2 | 0.03 | what is phases of validation in biopharm... |
160 | 2 | 0.03 | tablet dosagform brief rewev pdf |
161 | 2 | 0.03 | primary disease prevention in community ... |
162 | 2 | 0.03 | coprophilous fungi in nigeria. pdf |
163 | 2 | 0.03 | amaliaration of gentamicin induced nepro... |
164 | 2 | 0.03 | objective of cleaning validation in phar... |
165 | 2 | 0.03 | methods of extracting pharmaceutical oil... |
166 | 2 | 0.03 | extraction on cassia occidentalis pdf |
167 | 2 | 0.03 | salvia antimicrobia; activity |
168 | 2 | 0.03 | http://www.tjpr.org/vol4_no2/421editoria... |
169 | 2 | 0.03 | complications of brucellosis |
170 | 2 | 0.03 | trop j pharma res 2009, 8,3, 265 |
171 | 2 | 0.03 | simple hplc method for meloxicam |
172 | 2 | 0.03 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
173 | 2 | 0.03 | tropical journal of pharmaceutical resea... |
174 | 2 | 0.03 | pdf toothpaste |
175 | 2 | 0.03 | characterization of essential oils of py... |
176 | 2 | 0.03 | validation pharma |
177 | 2 | 0.03 | sustained release eudragit microspheres ... |
178 | 2 | 0.03 | pdf fille of pharmacutical validation pr... |
179 | 2 | 0.03 | formulation and evaluation of transderma... |
180 | 2 | 0.03 | disintegration time for orally disintegr... |
181 | 2 | 0.03 | official herbal ash value range of crude... |
182 | 2 | 0.03 | sem images for polymeric vesicles gel fo... |
183 | 2 | 0.03 | leaf aqueous extract alcoholic extract |
184 | 2 | 0.03 | assay of chloroquine phosphate using bac... |
185 | 2 | 0.03 | onstant of eda complex by spectroscopic ... |
186 | 2 | 0.03 | http://www.tjpr.org/jmanager/manuscript/... |
187 | 2 | 0.03 | analysis method of syrup metronidazole f... |
188 | 2 | 0.03 | http://www.tjpr.org/vol7_no3/734_bashir.... |
189 | 2 | 0.03 | example of transdermal dds |
190 | 2 | 0.03 | 大=naked |
191 | 2 | 0.03 | validation of pharmaceutical equipments |
192 | 2 | 0.03 | particulate drug delivery systems |
193 | 2 | 0.03 | dissolution lag time |
194 | 2 | 0.03 | basics of air validation +pdf |
195 | 2 | 0.03 | zhari ismail |
196 | 2 | 0.03 | present aspects of ethnobotany |
197 | 2 | 0.03 | amount of serum bilirubin in rats |
198 | 2 | 0.03 | stevia |
199 | 2 | 0.03 | manufacturing procedure of alkyd resin |
200 | 2 | 0.03 | garcinia kola extract |
201 | 2 | 0.03 | dfdfe49dcaa974f59a1244b8bcbf445c |
202 | 2 | 0.03 | cassia occidentalis |
203 | 2 | 0.03 | pharmacy validation |
204 | 2 | 0.03 | potential of pleurotus tuber regium in t... |
205 | 2 | 0.03 | pharma validations brief |
206 | 2 | 0.03 | validation in pharmaceutical |
207 | 2 | 0.03 | pharmaceutical platform technology pdf |
208 | 2 | 0.03 | unicef pharmacist programme |
209 | 2 | 0.03 | swietenia macrophylla charcoal |
210 | 2 | 0.03 | proniosome gel formulation |
211 | 2 | 0.03 | journal on introduction on tea.pdf |
212 | 2 | 0.03 | how can a lipid soluble drug reach the v... |
213 | 2 | 0.03 | why women in developing countries suffer... |
214 | 2 | 0.03 | preparation of nanoparticles from leaf e... |
215 | 2 | 0.03 | report and research on terminalia glauce... |
216 | 2 | 0.03 | akbarzade.zakie |
217 | 2 | 0.03 | multiparticulate drug delivery system |
218 | 2 | 0.03 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
219 | 2 | 0.03 | evaluation objective of primary health c... |
220 | 2 | 0.03 | chitosan molecular weight |
221 | 2 | 0.03 | bioanalytical method development of losa... |
222 | 2 | 0.03 | pdf file of green tea advantage |
223 | 2 | 0.03 | method of preparation complexation?q=met... |
224 | 2 | 0.03 | ir of ciprofloxacin |
225 | 2 | 0.03 | alstonia boonei pdf |
226 | 2 | 0.03 | standard range for ast , alt and alp bio... |
227 | 2 | 0.03 | product validation & pharma manufacturin... |
228 | 2 | 0.03 | menthol as penetration enhancer |
229 | 2 | 0.03 | commercial bus drivers in nigeria pdf |
230 | 2 | 0.03 | white tea+ catechin + gallates + useful... |
231 | 2 | 0.03 | therapeutic use of albizia zygia |
232 | 2 | 0.03 | spa beads cancer |
233 | 2 | 0.03 | research article on famotidine |
234 | 2 | 0.03 | gastroretentive drug release system.pdf |
235 | 2 | 0.03 | nanotechnology in drug delivery pdf?q=na... |
236 | 2 | 0.03 | mechanism of action of gatifloxacin pdf |
237 | 2 | 0.03 | &si=ciqunsha9rscfaql4godxmwasg |
238 | 2 | 0.03 | the role of a community pharmacist in de... |
239 | 2 | 0.03 | knowledge, attitude and practice towards... |
240 | 2 | 0.03 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
241 | 2 | 0.03 | analysis method syrup metronidazole file... |
242 | 2 | 0.03 | www.internal control measures in hospita... |
243 | 2 | 0.03 | in process control evaluation |
244 | 2 | 0.03 | dna extraction in boswellia serrata |
245 | 2 | 0.03 | methods of preparing microcapsule |
246 | 2 | 0.03 | effect of lecithin in the treatment of e... |
247 | 2 | 0.03 | chalcone anticancer |
248 | 2 | 0.03 | formulation of nanospheres |
249 | 2 | 0.03 | effect nissl staining pdf |
250 | 2 | 0.03 | 73995f73c7e62663f3ca3c4c0b2ce78c |
251 | 2 | 0.03 | normal value of bilirubin in rat |
252 | 2 | 0.03 | introduction on garcinia kola pdf |
253 | 2 | 0.03 | challenges faced by herbal practitionist |
254 | 2 | 0.03 | biochemical and molecular approach to co... |
255 | 2 | 0.03 | amaliaration of gentamicin induced nepro... |
256 | 2 | 0.03 | efficacy of 5 brands of toothpaste for r... |
257 | 2 | 0.03 | research article on time spent by patien... |
258 | 2 | 0.03 | process validation of raw material in ph... |
259 | 2 | 0.03 | geology of iyanomo benin edo state |
260 | 2 | 0.03 | artical on metronidazole and accelofenac... |
261 | 2 | 0.03 | what are the plants analysed to have ins... |
262 | 2 | 0.03 | starch rx-1500 |
263 | 2 | 0.03 | silymarin |
264 | 2 | 0.03 | what is multiparticulate drug delivery s... |
265 | 2 | 0.03 | trop j pharmacy res 8 3 265,2009 |
266 | 2 | 0.03 | micelles preparation method |
267 | 2 | 0.03 | drug delivery system in relation to chem... |
268 | 2 | 0.03 | orally disintegrating tablets pdf |
269 | 2 | 0.03 | introduction to tea polyphenols benefits |
270 | 2 | 0.03 | definition of locus of control in nigeri... |
271 | 2 | 0.03 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
272 | 2 | 0.03 | hematuria, low c3, low c4, high ana |
273 | 2 | 0.03 | avicel ph 101 specification |
274 | 2 | 0.03 | mic report pharmaceuticals of bangladesh |
275 | 2 | 0.03 | 3f8c91b85ec27f514e33f10d0070a24b |
276 | 2 | 0.03 | traditional medical demand and developme... |
277 | 2 | 0.03 | microbial quality of blood tonic syrup |
278 | 2 | 0.03 | tea and health pdf |
279 | 2 | 0.03 | properties of terminalia glaucescens +jo... |
280 | 2 | 0.03 | ibuprofen pdf |
281 | 2 | 0.03 | anticancer amaranthus tricolor l |
282 | 2 | 0.03 | terminalia glaucescens + pdf + journal |
283 | 2 | 0.03 | methanol & methylene dichloride |
284 | 2 | 0.03 | how yo.prepare sif ph 7.4 medium |
285 | 2 | 0.03 | thesis of proniosome gel of acyclovir |
286 | 2 | 0.03 | c3 and c4 have any role in diagonosis of... |
287 | 2 | 0.03 | chemistry-wet digestion using nitric aci... |
288 | 2 | 0.03 | importance of milk in nigeria pdf |
289 | 2 | 0.03 | are sennosides an indicator? |
290 | 2 | 0.03 | drug- resistant bacterial pathogen in mi... |
291 | 2 | 0.03 | chitosan nanoparticles+trehalose |
292 | 2 | 0.03 | pharmaceutical process validation |
293 | 2 | 0.03 | filetype:pdf acute and subacute toxicity... |
294 | 2 | 0.03 | ethanolic extraction method |
295 | 2 | 0.03 | actinomycetes enzyme production |
296 | 2 | 0.03 | act antimalarial pdf nigeria |
297 | 2 | 0.03 | validation techniques for pharmaceutical... |
298 | 2 | 0.03 | effects of cassia occidentalis leaf extr... |
299 | 2 | 0.03 | validation department in pharmaceutical ... |
300 | 2 | 0.03 | writing concluson in ointment preparatio... |
301 | 2 | 0.03 | what is the benifits of green tea pdf |
302 | 2 | 0.03 | tea and health , pdf |
303 | 1 | 0.01 | who pharmaceutical validation |
304 | 1 | 0.01 | test for assessing milk quality?q=test f... |
305 | 1 | 0.01 | traditional medicine in nigeria pdf |
306 | 1 | 0.01 | mefenamic acid thesis |
307 | 1 | 0.01 | pdf of anticancer activity by using mtt ... |
308 | 1 | 0.01 | penetration enhancers ppt |
309 | 1 | 0.01 | anayatollah salimi |
310 | 1 | 0.01 | &ptb=291ca299-ae1d-46f3-acb5-4ff2ff850e2... |
311 | 1 | 0.01 | barabadi hamed |
312 | 1 | 0.01 | http://www.tjpr.org/vol7_no2/725sahu.pdf |
313 | 1 | 0.01 | antibacterial activities of plants again... |
314 | 1 | 0.01 | alkyd pdf |
315 | 1 | 0.01 | research paper on metrinidazole and any ... |
316 | 1 | 0.01 | "college of pharmacy" india synthesis |
317 | 1 | 0.01 | diuretic activity of medicinal plants |
318 | 1 | 0.01 | name of 3 non floating gastro retentive ... |
319 | 1 | 0.01 | progress in controlled gastroretentive d... |
320 | 1 | 0.01 | characterization of asparaginase pdf |
321 | 1 | 0.01 | ca alginate dsc |
322 | 1 | 0.01 | kang mn, rizio l, prybicien m, middlemas... |
323 | 1 | 0.01 | http://www.tjpr.org/vol7_no3/734_bashir.... |
324 | 1 | 0.01 | meprobamate bcs class |
325 | 1 | 0.01 | lumifantrine dissolution |
326 | 1 | 0.01 | in vitro antiurolithiatic assay |
327 | 1 | 0.01 | knowledge regarding diarrheal management... |
328 | 1 | 0.01 | how to improve patient satisfaction at p... |
329 | 1 | 0.01 | herbal toothpaste formulation pdf |
330 | 1 | 0.01 | validation in pharmaceutical quality ass... |
331 | 1 | 0.01 | test for antipyretic effect on mice |
332 | 1 | 0.01 | proniosomes |
333 | 1 | 0.01 | does brucellosis delay menturation? |
334 | 1 | 0.01 | formulation of the extract of the stem b... |
335 | 1 | 0.01 | c99aeb95a4446d3f8bb41643873ddf78 |
336 | 1 | 0.01 | african journal of pharmaceutical scienc... |
337 | 1 | 0.01 | amin a f emerging trends in orally disin... |
338 | 1 | 0.01 | pharmacuitical validation |
339 | 1 | 0.01 | nano scale devices for drug delivery and... |
340 | 1 | 0.01 | phytochemical screening test of hnna |
341 | 1 | 0.01 | tropical journal of pharmaceutical scien... |
342 | 1 | 0.01 | ideal chemical enhancer |
343 | 1 | 0.01 | formulation of tramadol tablets |
344 | 1 | 0.01 | differential scanning calorimetry of fur... |
345 | 1 | 0.01 | eudragit rl and solubility in acid |
346 | 1 | 0.01 | thiol drug delivery |
347 | 1 | 0.01 | modified mucoadhesive material for enhan... |
348 | 1 | 0.01 | controlled release drug delivery system ... |
349 | 1 | 0.01 | stability indicating |
350 | 1 | 0.01 | metformin gel in delhi |
351 | 1 | 0.01 | six film periodontal |
352 | 1 | 0.01 | how to determine the packing fraction of... |
353 | 1 | 0.01 | balanced equation between chloroquine ph... |
354 | 1 | 0.01 | lai zq |
355 | 1 | 0.01 | formulation of ampul vitamin b complex p... |
356 | 1 | 0.01 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
357 | 1 | 0.01 | what is the process of studying food and... |
358 | 1 | 0.01 | pdf cerebellar cortex layer |
359 | 1 | 0.01 | mitracarpus villous pdf |
360 | 1 | 0.01 | orally disintegrating tablet, bioequival... |
361 | 1 | 0.01 | filetype:pdf acute and subacute toxicity... |
362 | 1 | 0.01 | edgar f moran palacio |
363 | 1 | 0.01 | furosemide dissolution |
364 | 1 | 0.01 | ir spectra of carbopol 934 |
365 | 1 | 0.01 | brown d., 2001. orally disintegrating ta... |
366 | 1 | 0.01 | artocarpus altilis leaves |
367 | 1 | 0.01 | assessment of microbial contamination o... |
368 | 1 | 0.01 | clitoria ternatea blood |
369 | 1 | 0.01 | enhancers in transdermal drug delivery |
370 | 1 | 0.01 | fdt promethazin |
371 | 1 | 0.01 | 2014 nutrition composition of stevia |
372 | 1 | 0.01 | reduce waiting times for patients at pha... |
373 | 1 | 0.01 | osmotic tablet pk data |
374 | 1 | 0.01 | ketoprofen transdermal pacth filetype:pd... |
375 | 1 | 0.01 | pdf antipyretic plant extracts |
376 | 1 | 0.01 | when were physicians and pharmacists div... |
377 | 1 | 0.01 | tropi j of pha research |
378 | 1 | 0.01 | tropical journal of pharmsceutical resea... |
379 | 1 | 0.01 | development and optimization of insulin-... |
380 | 1 | 0.01 | how to increase c3 complement level |
381 | 1 | 0.01 | review on process validation |
382 | 1 | 0.01 | http://www.tjpr.org/vol8_no1/2009_8_1_7.... |
383 | 1 | 0.01 | multiparticulate drug delivery system |
384 | 1 | 0.01 | diuretic activity of medicinal plants pd... |
385 | 1 | 0.01 | antidiarrhoeal |
386 | 1 | 0.01 | effect jasmonat on fruit plants |
387 | 1 | 0.01 | tuberculosis |
388 | 1 | 0.01 | studies on commercial bus drivers pdf |
389 | 1 | 0.01 | sugar sphere in controlled drug delivery |
390 | 1 | 0.01 | gastro retentive drug delivery system re... |
391 | 1 | 0.01 | garcinia kola pdf |
392 | 1 | 0.01 | glycerin penetration enhancer |
393 | 1 | 0.01 | preparation of thiozolidinones |
394 | 1 | 0.01 | pdf-enojukan j.f,adeniyi a.community pha... |
395 | 1 | 0.01 | muhammad wahab amjad malaysia |
396 | 1 | 0.01 | ointment pdf |
397 | 1 | 0.01 | chitosan medium molecular weight |
398 | 1 | 0.01 | decreased c3 and c4 serum complement |
399 | 1 | 0.01 | http://www.tjpr.org/vol8_no2/2009_8_2_10... |
400 | 1 | 0.01 | protocol for na alginate solution electr... |
401 | 1 | 0.01 | ondansetronhydrochloride and beta cyclod... |
402 | 1 | 0.01 | tropical journal of pharmacentical resea... |
403 | 1 | 0.01 | antimicrobial studies on pseudomonas aer... |
404 | 1 | 0.01 | skin absortion enhancers |
405 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
406 | 1 | 0.01 | benefits of african rooblong red tea |
407 | 1 | 0.01 | assay of chloroquin phosphate |
408 | 1 | 0.01 | snakes in nigera |
409 | 1 | 0.01 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
410 | 1 | 0.01 | nigeria hospital guidelines |
411 | 1 | 0.01 | wood chemistry full text pdf |
412 | 1 | 0.01 | women's health and economic security dev... |
413 | 1 | 0.01 | tropical journal of pharmaceuticalresear... |
414 | 1 | 0.01 | udeogaranya @gmail.com |
415 | 1 | 0.01 | proximate analysis of picralima nitida |
416 | 1 | 0.01 | meye ganyan rai dore |
417 | 1 | 0.01 | sixgram |
418 | 1 | 0.01 | trop j pharm res impact factor |
419 | 1 | 0.01 | standard calibration curve of terbinafin... |
420 | 1 | 0.01 | dsdna normal with low complements] |
421 | 1 | 0.01 | download journal antipyretic.pdf |
422 | 1 | 0.01 | factorial design of controlled release d... |
423 | 1 | 0.01 | ipqa in pharma pdf |
424 | 1 | 0.01 | definitions of an entrepreneur by stanki... |
425 | 1 | 0.01 | data for project on typhoid fever in nig... |
426 | 1 | 0.01 | china agricultural university+liu qi-zhi... |
427 | 1 | 0.01 | 6. physical and chemical penetration enh... |
428 | 1 | 0.01 | woolfall j. c. an approach to product fo... |
429 | 1 | 0.01 | bioactive nanoparticles in pdf format in... |
430 | 1 | 0.01 | bioavailability required for fast disint... |
431 | 1 | 0.01 | nigerian journal of pharmaceuticals scie... |
432 | 1 | 0.01 | journals on nanotechnology in pdf |
433 | 1 | 0.01 | factors influencing the dispensing |
434 | 1 | 0.01 | pdf of micro sphere |
435 | 1 | 0.01 | phosphate buffer 6.9 mobile phase |
436 | 1 | 0.01 | modern ethnobotany |
437 | 1 | 0.01 | c3 and c4 serum complement deficiency |
438 | 1 | 0.01 | hadeel el zayyat |
439 | 1 | 0.01 | indian medicinal plants antimicrobial ac... |
440 | 1 | 0.01 | penetration enhancer |
441 | 1 | 0.01 | nmr of β-sitosteryl-d-glycoside |
442 | 1 | 0.01 | letrozole tablets in coimbatore |
443 | 1 | 0.01 | low complement c3 and c4 |
444 | 1 | 0.01 | ;tropical journal of pharmaceutical rese... |
445 | 1 | 0.01 | advantages for the consumption of tea |
446 | 1 | 0.01 | journals on comparing inorganic componen... |
447 | 1 | 0.01 | asparginase pdf |
448 | 1 | 0.01 | finasteride tween-80 |
449 | 1 | 0.01 | the effect of chitosan molecular weight ... |
450 | 1 | 0.01 | recent trends inhypertension managements... |
451 | 1 | 0.01 | &ptb=33bd169f-d0e1-451b-aeb8-38e79f36a4e... |
452 | 1 | 0.01 | serum complement levels in lupus |
453 | 1 | 0.01 | purification flavonoids |
454 | 1 | 0.01 | nutmeg clinical effects pdf |
455 | 1 | 0.01 | pdf arricles of microspheres |
456 | 1 | 0.01 | suppository pdf |
457 | 1 | 0.01 | stevia extract salicylate |
458 | 1 | 0.01 | effect+garcinia+kola +liver +enzymes+rat... |
459 | 1 | 0.01 | jounals on groundwater quality in ikpoba... |
460 | 1 | 0.01 | s r and c r drug delivery |
461 | 1 | 0.01 | low complement c3, low complement c4, hi... |
462 | 1 | 0.01 | pdf the sociology of community pharmacy ... |
463 | 1 | 0.01 | duplag03@yahoo.com |
464 | 1 | 0.01 | folic acid as a contaminant to nutrient ... |
465 | 1 | 0.01 | journal formulation and manufacturing ta... |
466 | 1 | 0.01 | what is a good c3 level |
467 | 1 | 0.01 | uritca dioica |
468 | 1 | 0.01 | tropical jounral of pharmacuetical scien... |
469 | 1 | 0.01 | agar agar to make toothpaste |
470 | 1 | 0.01 | afsana-al-sharmin |
471 | 1 | 0.01 | cleaning, process development and valida... |
472 | 1 | 0.01 | naturally avaliable crosslinked agent pd... |
473 | 1 | 0.01 | ic5o of ursolic acid |
474 | 1 | 0.01 | antioxidant and hypoglycemic effects of ... |
475 | 1 | 0.01 | drug delivery methods pdf |
476 | 1 | 0.01 | allowed delay delay in patient waiting t... |
477 | 1 | 0.01 | www.tipr.org |
478 | 1 | 0.01 | amer hayat khan |
479 | 1 | 0.01 | antimicrobial studies of raw extracts of... |
480 | 1 | 0.01 | aspirin and paper packaging |
481 | 1 | 0.01 | aspects of microbial contamination of ta... |
482 | 1 | 0.01 | clinical features of snake bite in niger... |
483 | 1 | 0.01 | comparison of obstetric complications in... |
484 | 1 | 0.01 | limits for pharmaceautical product yield |
485 | 1 | 0.01 | laxative with phenolphthalein |
486 | 1 | 0.01 | formulation and evaluation of cyprohepta... |
487 | 1 | 0.01 | http://tjpr.org/jmanager/manuscript/edit... |
488 | 1 | 0.01 | autoimmune profile c4 |
489 | 1 | 0.01 | artocarpus altilis, medicinal uses of... |
490 | 1 | 0.01 | www.international journal of turmeric of... |
491 | 1 | 0.01 | adebayo lamikanra |
492 | 1 | 0.01 | brittle fracture problems in pharmaceuti... |
493 | 1 | 0.01 | colony bactery count saliva method nutri... |
494 | 1 | 0.01 | www.tjpr.org/..2009_8_4_7_igbe.pdf |
495 | 1 | 0.01 | vitamin in quercus+pdf |
496 | 1 | 0.01 | what are the method use to screened plan... |
497 | 1 | 0.01 | permeability of ahvaz |
498 | 1 | 0.01 | sesamin ppar gamma |
499 | 1 | 0.01 | modulation of drug release in a dosage f... |
500 | 1 | 0.01 | flavonoids,tannins and saponins in picra... |
501 | 1 | 0.01 | evaluation of antibacterial activity of ... |
502 | 1 | 0.01 | odukoya oo |
503 | 1 | 0.01 | tagetes erectus medicinal uses |
504 | 1 | 0.01 | ibuprofen solubility in propylene glycol |
505 | 1 | 0.01 | interpritation of theophylline by dsc |
506 | 1 | 0.01 | cell morphological assessment +extract+p... |
507 | 1 | 0.01 | brittle fracture tabletting |
508 | 1 | 0.01 | enojukan jf,adeniyi a-community pharmaci... |
509 | 1 | 0.01 | ibrahim jantan |
510 | 1 | 0.01 | role of intrepreneurship in pharmacy |
511 | 1 | 0.01 | propylene glycol as penetration enhancer... |
512 | 1 | 0.01 | platform technologies in pharmaceutical ... |
513 | 1 | 0.01 | prescription technology validate product... |
514 | 1 | 0.01 | uv spectrum dextromethorphan hplc 2d6 de... |
515 | 1 | 0.01 | antimicrobial activity of flavanoids |
516 | 1 | 0.01 | betahistine mesylate, dissolution |
517 | 1 | 0.01 | 14947 |
518 | 1 | 0.01 | analytical method for meloxicam uv |
519 | 1 | 0.01 | screening methods for diuretic activity |
520 | 1 | 0.01 | recent trends in ethnobotanical study |
521 | 1 | 0.01 | urtica dioica |
522 | 1 | 0.01 | causes of low c3 and c4 levels |
523 | 1 | 0.01 | salvia+extract+antibacterial+pdf |
524 | 1 | 0.01 | preparation of alkyd resins using monogl... |
525 | 1 | 0.01 | mefenamic acid capsule formulation proce... |
526 | 1 | 0.01 | marketing of herbal products in ghana |
527 | 1 | 0.01 | microencapsulated |
528 | 1 | 0.01 | navaneethan, hplc |
529 | 1 | 0.01 | poisonous snakes in nigeria |
530 | 1 | 0.01 | pharmacognostic evaluation |
531 | 1 | 0.01 | nanotechnology article pdf |
532 | 1 | 0.01 | pdf on snakebite in dogs and treatment i... |
533 | 1 | 0.01 | brittle fracture tableting excipients li... |
534 | 1 | 0.01 | beer lambert's plot for chloroquine phos... |
535 | 1 | 0.01 | captopril intestine |
536 | 1 | 0.01 | designs of multiparticulate drug deliver... |
537 | 1 | 0.01 | broad spectrum antimicrobial plant extra... |
538 | 1 | 0.01 | the use of complement 3 and 4 in sle |
539 | 1 | 0.01 | process validation in pharmaceutical ind... |
540 | 1 | 0.01 | impact factor of tropical journal of pha... |
541 | 1 | 0.01 | how to downloa dajibola olaniyi experime... |
542 | 1 | 0.01 | thiolated polymers in vaginal drug deliv... |
543 | 1 | 0.01 | antimicrobial activity of some indian me... |
544 | 1 | 0.01 | azone penetration enhancer |
545 | 1 | 0.01 | tropical pharmaceutical journal |
546 | 1 | 0.01 | why pharmaceutical validation |
547 | 1 | 0.01 | monolithic drug delivery systems/starch+... |
548 | 1 | 0.01 | pronisomal gel of captopril procedure |
549 | 1 | 0.01 | fast dispersible tablets 2013 |
550 | 1 | 0.01 | chemical enhancers คือ |
551 | 1 | 0.01 | enzyme l - asparaginase isolated from mi... |
552 | 1 | 0.01 | ground water condition of benin |
553 | 1 | 0.01 | panadol night |
554 | 1 | 0.01 | american journal of pharmacy and health ... |
555 | 1 | 0.01 | alcoholic extraction of aloe vera |
556 | 1 | 0.01 | reporting,antimicrobial,activities, pdf |
557 | 1 | 0.01 | nanotechnology in drug delivery book fre... |
558 | 1 | 0.01 | prescribing patterns and inappropriate u... |
559 | 1 | 0.01 | vitamin content in heracleum and the eff... |
560 | 1 | 0.01 | reviwe of knedinging method filetype:pd... |
561 | 1 | 0.01 | where can i get quality jerseys to buy i... |
562 | 1 | 0.01 | various type of validation in pharma |
563 | 1 | 0.01 | studies on energy drinks in the gulf reg... |
564 | 1 | 0.01 | penetration enhancer 2004+pdf |
565 | 1 | 0.01 | dispensing of tablets from large packs i... |
566 | 1 | 0.01 | kneading time determination |
567 | 1 | 0.01 | microspheres on metronidazol and aspirin... |
568 | 1 | 0.01 | antiproliferative effect of l mtt assay |
569 | 1 | 0.01 | anticancer properties of gumamela extrac... |
570 | 1 | 0.01 | www33babacom |
571 | 1 | 0.01 | chemistry of ciprofloxacin pdf |
572 | 1 | 0.01 | david n'guessan bioscience |
573 | 1 | 0.01 | c3 & c4 level in sle nephritis |
574 | 1 | 0.01 | evaluation of palm oil-based paracetamol... |
575 | 1 | 0.01 | l asparaginase a review pdf |
576 | 1 | 0.01 | antibacterial activity of extract mic mb... |
577 | 1 | 0.01 | tropical journal of pharmaceutical rese... |
578 | 1 | 0.01 | &source=web |
579 | 1 | 0.01 | disintegration of tablets pdf |
580 | 1 | 0.01 | osteoporosis malaysia |
581 | 1 | 0.01 | nasal inserts |
582 | 1 | 0.01 | nanostructured lipid carrier |
583 | 1 | 0.01 | nanotechnology articles+pdf |
584 | 1 | 0.01 | tropical j.pharm res. |
585 | 1 | 0.01 | response surface optimized extraction o... |
586 | 1 | 0.01 | assessment of microbial contamination of... |
587 | 1 | 0.01 | which dye is used to test the presence o... |
588 | 1 | 0.01 | transdermal with dmso |
589 | 1 | 0.01 | tropical gournal |
590 | 1 | 0.01 | filetype:pdf chemical compound in stevia |
591 | 1 | 0.01 | function of acetonitrile with glacial ac... |
592 | 1 | 0.01 | justification writing for pharmaceutical... |
593 | 1 | 0.01 | mucin.pdf |
594 | 1 | 0.01 | nanocrystal marketing brands in cardiac ... |
595 | 1 | 0.01 | lupus and low c3 c4 |
596 | 1 | 0.01 | eudragit rl 100 microspheres |
597 | 1 | 0.01 | journal gen broiler chicken |
598 | 1 | 0.01 | aspirin lung injury |
599 | 1 | 0.01 | calendula officinalis bhushan muley tjpr |
600 | 1 | 0.01 | disintegration temprature for oroddisper... |
601 | 1 | 0.01 | suppository |
602 | 1 | 0.01 | snakes of nigeria |
603 | 1 | 0.01 | neurobehavioural studies and chloroquine... |
604 | 1 | 0.01 | preparation and evaluation of famotidine... |
605 | 1 | 0.01 | 40040702 |
606 | 1 | 0.01 | what are multi unit particulate system (... |
607 | 1 | 0.01 | tropical journal of pharmacetical resese... |
608 | 1 | 0.01 | u v of chitosan+ciprofloxacin+tpp |
609 | 1 | 0.01 | preparation method for inclusion complex... |
610 | 1 | 0.01 | oximes in op poisoning |
611 | 1 | 0.01 | transdermal drug delivery system review ... |
612 | 1 | 0.01 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
613 | 1 | 0.01 | gastroretentive dosage forms in the mark... |
614 | 1 | 0.01 | drug development in pharmaceutical proce... |
615 | 1 | 0.01 | elevated c3 with normal c4 |
616 | 1 | 0.01 | metronidazole and acilofenace microspher... |
617 | 1 | 0.01 | mechanisms of drug permeation |
618 | 1 | 0.01 | phytochemical constituent of newbouldia ... |
619 | 1 | 0.01 | albert l, simon s. 1997. pharmaceutical |
620 | 1 | 0.01 | ziziphus mauritiana leaf prior |
621 | 1 | 0.01 | swellable agents in drug delivery system |
622 | 1 | 0.01 | np okolie |
623 | 1 | 0.01 | product to product cleaning procedure in... |
624 | 1 | 0.01 | different steps involved in installation... |
625 | 1 | 0.01 | complement c3 serum and complement c4 se... |
626 | 1 | 0.01 | boswellia serrata gum powder extract pdf |
627 | 1 | 0.01 | complement c3 and complement c4 serum |
628 | 1 | 0.01 | extract + apoptosis |
629 | 1 | 0.01 | j med aro pl sci 1998 20 |
630 | 1 | 0.01 | ethnomedical uses, common name, toxicity... |
631 | 1 | 0.01 | evaluation and quantitative determinatio... |
632 | 1 | 0.01 | effect of gentamicin with bcomplex |
633 | 1 | 0.01 | dr mathew ikhuoria arhewoh of uniben |
634 | 1 | 0.01 | elevated c3 and c4 with normal esr |
635 | 1 | 0.01 | ernest kuchar poland |
636 | 1 | 0.01 | novel research in transdermal delivery s... |
637 | 1 | 0.01 | multiparticulate drug delivery systems |
638 | 1 | 0.01 | hydrogeology of benin city |
639 | 1 | 0.01 | mefenamic pdf |
640 | 1 | 0.01 | research methodologies - araoye |
641 | 1 | 0.01 | reashrch articleproniosome gel formulati... |
642 | 1 | 0.01 | sukun plant |
643 | 1 | 0.01 | artocarpus altilis |
644 | 1 | 0.01 | allintext: extract aizoaceae, or activit... |
645 | 1 | 0.01 | antioxidant and hypoglycemic effects of ... |
646 | 1 | 0.01 | production of extracellular anti-leukaem... |
647 | 1 | 0.01 | tropical journal l |
648 | 1 | 0.01 | aldrich chitosan no.44887-7 meadium mole... |
649 | 1 | 0.01 | garcinia kola and drug interactions |
650 | 1 | 0.01 | formulation and evaluation of emetic dr... |
651 | 1 | 0.01 | http://www.tjpr.org/vol10_no6/2011_10_6_... |
652 | 1 | 0.01 | guo p. preface: a special issue on biona... |
653 | 1 | 0.01 | pathway oleic acid of skin pdf |
654 | 1 | 0.01 | 'not assigned' manuscript status |
655 | 1 | 0.01 | low c3 and c4 with normal ana |
656 | 1 | 0.01 | pharmaceutical validation testing |
657 | 1 | 0.01 | transdermal chemicals |
658 | 1 | 0.01 | high c3 and c4 means |
659 | 1 | 0.01 | c4 lupus nephritis |
660 | 1 | 0.01 | evaluation of microspheres |
661 | 1 | 0.01 | low complement levels |
662 | 1 | 0.01 | stability indicating method by hplc |
663 | 1 | 0.01 | kneading method beta-cyclodextrin pdf |
664 | 1 | 0.01 | identification of pure drug by ftir/lamu... |
665 | 1 | 0.01 | isopropyl palmitate (palm oil) certifica... |
666 | 1 | 0.01 | b- sitosterol nmr and mass spectrum file |
667 | 1 | 0.01 | author:kette faye |
668 | 1 | 0.01 | challenges in traditional medicine |
669 | 1 | 0.01 | difference salbutamol and salbutamol sul... |
670 | 1 | 0.01 | table ofcontent on phytochemical screeni... |
671 | 1 | 0.01 | uses of herbs, pdf |
672 | 1 | 0.01 | (http://www.tjpr.org |
673 | 1 | 0.01 | antimicrobial activity of some salvia sp... |
674 | 1 | 0.01 | validation techniques in pharmaceutical ... |
675 | 1 | 0.01 | solvent evaporation method for microsphe... |
676 | 1 | 0.01 | nigerian poisonous snakes |
677 | 1 | 0.01 | hilda rastegari electroporation pdf |
678 | 1 | 0.01 | importan of ground water |
679 | 1 | 0.01 | liposome transdermal patch thesis |
680 | 1 | 0.01 | carissa carandas adverse effect |
681 | 1 | 0.01 | betamethazone in buffered cream |
682 | 1 | 0.01 | boswellia serrata anti inflammatory acti... |
683 | 1 | 0.01 | finger print |
684 | 1 | 0.01 | plga ratio determination |
685 | 1 | 0.01 | screening steroid using thin layer chrom... |
686 | 1 | 0.01 | deepika sharma rajesh kumari manhas |
687 | 1 | 0.01 | a~n~t~i~p~r~o~l~i~f~e~r~a~t~i~v~e~%~2~0~... |
688 | 1 | 0.01 | challenges of herbal medicine use |
689 | 1 | 0.01 | transdermal skin delivery |
690 | 1 | 0.01 | questionnaire to pharmacist about typhoi... |
691 | 1 | 0.01 | warfarin use saudi arabia |
692 | 1 | 0.01 | drug delivery and controlled release |
693 | 1 | 0.01 | dulgar g, aki c (2009). antimicrobial ac... |
694 | 1 | 0.01 | multiparticulate formulation |
695 | 1 | 0.01 | in vivo herbal healthy in human voluntee... |
696 | 1 | 0.01 | pharma review articles pdf |
697 | 1 | 0.01 | pharmacokinetic eurycoma longifolia jack |
698 | 1 | 0.01 | trop j of pharm research |
699 | 1 | 0.01 | studies on the epidemiology and clincal ... |
700 | 1 | 0.01 | propionibacterium pongamia pinnata |
701 | 1 | 0.01 | explain pharmacy technician in nigeria p... |
702 | 1 | 0.01 | enojukan j.f,adeniyi a-research on commu... |
703 | 1 | 0.01 | validation in pharma |
704 | 1 | 0.01 | www.hik-online/mgr1%2\x0317244ea586bad59... |
705 | 1 | 0.01 | modified release drug delivery system p... |
706 | 1 | 0.01 | disadvantages peroral route |
707 | 1 | 0.01 | black mulberry analysis anthocyanin spec... |
708 | 1 | 0.01 | drug interaction+caffeine+pdf |
709 | 1 | 0.01 | nigerian standard for hospital pharmacy |
710 | 1 | 0.01 | journal of tropical pharmaceutical resea... |
711 | 1 | 0.01 | lipid nanoparticles |
712 | 1 | 0.01 | antibiotic sensitivity urine paper pdf d... |
713 | 1 | 0.01 | effect of solvent system on drug release |
714 | 1 | 0.01 | sesamin and adipogenesis |
715 | 1 | 0.01 | moringa oleifera use statistics on drug ... |
716 | 1 | 0.01 | low c3 and normal c4 |
717 | 1 | 0.01 | why is complement c4 increase |
718 | 1 | 0.01 | mitracarpus scaber zucc plant |
719 | 1 | 0.01 | medium molecular weight chitosan |
720 | 1 | 0.01 | determination of potency of ciprofloxaci... |
721 | 1 | 0.01 | e.coli as antimicrobial isolate of urine... |
722 | 1 | 0.01 | what benefits of disintegrating tablets |
723 | 1 | 0.01 | attitude and belief of herbal medicine t... |
724 | 1 | 0.01 | antibacterial activity possessed by med... |
725 | 1 | 0.01 | تعیین lod و loq hplc |
726 | 1 | 0.01 | what does c4 serum and c3 serum measure |
727 | 1 | 0.01 | ficus vegf inhibition |
728 | 1 | 0.01 | release mechanisms in drug delivery past... |
729 | 1 | 0.01 | sennosides dosage form |
730 | 1 | 0.01 | mi ali mohammad sabzghabaee journal |
731 | 1 | 0.01 | in process control pharmaceutical |
732 | 1 | 0.01 | tropical j pharm res |
733 | 1 | 0.01 | tjpls |
734 | 1 | 0.01 | terminalia pallida bark |
735 | 1 | 0.01 | phytochemical found in vernonia amgydal... |
736 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
737 | 1 | 0.01 | cleaning validation protocol |
738 | 1 | 0.01 | hunteria umbellata pharmaceutical functi... |
739 | 1 | 0.01 | pharmaceutical process validation sop |
740 | 1 | 0.01 | morinda morindoides |
741 | 1 | 0.01 | effects of ethanol and aqueous extracts ... |
742 | 1 | 0.01 | chemical constituents of carissa carrand... |
743 | 1 | 0.01 | introduction to assessment of microbial ... |
744 | 1 | 0.01 | antimicrobial activity pdf |
745 | 1 | 0.01 | vibhuti sgsits |
746 | 1 | 0.01 | the major challenges of herbal medicine |
747 | 1 | 0.01 | tropical journal of pharmacology |
748 | 1 | 0.01 | artocarpus altilis pdf |
749 | 1 | 0.01 | bacterial co tamination of ground water ... |
750 | 1 | 0.01 | disintegrating agents used in tablets pd... |
751 | 1 | 0.01 | c3 c4 levels |
752 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
753 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
754 | 1 | 0.01 | http://tjpr.org/jmanager/manuscript/logi... |
755 | 1 | 0.01 | brucellosis treatment |
756 | 1 | 0.01 | what is tea pdf |
757 | 1 | 0.01 | chronic low c3 levels |
758 | 1 | 0.01 | chemical enhancers transdermal delivery |
759 | 1 | 0.01 | clonidine hydrochloride biodegradable |
760 | 1 | 0.01 | coffee effect on s. aureus |
761 | 1 | 0.01 | bioochemical analysis of the leaf extrac... |
762 | 1 | 0.01 | 4-hydroxy-5-methoxycanthin-6-one |
763 | 1 | 0.01 | recent trends of ethnobotany in north ea... |
764 | 1 | 0.01 | http://www.tjpr.org/vol7_no3/939_dey.pdf |
765 | 1 | 0.01 | energy drink abuse in saudi |
766 | 1 | 0.01 | multiparticulate pulsatile drug delivery... |
767 | 1 | 0.01 | snake bite and envenomation in children ... |
768 | 1 | 0.01 | green tea pdf |
769 | 1 | 0.01 | famotidine solubility profile.pdf |
770 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
771 | 1 | 0.01 | trop j of pha res |
772 | 1 | 0.01 | what are all the materials used in nanot... |
773 | 1 | 0.01 | aditya arya |
774 | 1 | 0.01 | ehikhamenor and agwubike |
775 | 1 | 0.01 | 083d996f79e1a4f1405bc20135dc65c3 |
776 | 1 | 0.01 | medium molecular weight of chitosan |
777 | 1 | 0.01 | analysis of extracts of cassia occident... |
778 | 1 | 0.01 | equipment validation pharmaceuticals |
779 | 1 | 0.01 | research article on recent development o... |
780 | 1 | 0.01 | preparation of microsponges |
781 | 1 | 0.01 | tramadol formula tablets and used excipi... |
782 | 1 | 0.01 | terminalia glaucescens |
783 | 1 | 0.01 | results on phytochemical test on various... |
784 | 1 | 0.01 | preparation of microspheres by the solve... |
785 | 1 | 0.01 | prescribing patterns and inappropriate u... |
786 | 1 | 0.01 | nanotechnology drug delivery review pdf |
787 | 1 | 0.01 | nigerian mothers malaria belief |
788 | 1 | 0.01 | olmesartan fist disintegrating tablets |
789 | 1 | 0.01 | what is the side effect of act anti mala... |
790 | 1 | 0.01 | tropical j of pharmaceutical research |
791 | 1 | 0.01 | validation in pharmaceutical manufacturi... |
792 | 1 | 0.01 | azones, pyrrolidones in transdermal |
793 | 1 | 0.01 | www.poracom hindi |
794 | 1 | 0.01 | block copolymers applications |
795 | 1 | 0.01 | chemical analysis for tea pdf |
796 | 1 | 0.01 | human leukocyte antigen-dr hiv |
797 | 1 | 0.01 | http://www.tjpr.org/vol13_no3/2014_13_3_... |
798 | 1 | 0.01 | design and evaluation of transdermal pat... |
799 | 1 | 0.01 | complement c4 serum kevel 35 |
800 | 1 | 0.01 | gulzar ciprofloxacin diclofenac dental g... |
801 | 1 | 0.01 | herbs for ailments pdf |
802 | 1 | 0.01 | abbot company,s medicine consist of milk... |
803 | 1 | 0.01 | usage of alkyd resin in food coating |
804 | 1 | 0.01 | tropical journal phar |
805 | 1 | 0.01 | antioxidant and hypoglycemic effects of ... |
806 | 1 | 0.01 | advantages of gastric retention drug del... |
807 | 1 | 0.01 | chemical penetration through the skin |
808 | 1 | 0.01 | multiparticulate sustain release doasge ... |
809 | 1 | 0.01 | mitochondrial membrane potential jc-1 |
810 | 1 | 0.01 | high complementc3 c4 levels |
811 | 1 | 0.01 | methanol extract |
812 | 1 | 0.01 | drug interaction+caffeine+human+pdf |
813 | 1 | 0.01 | soap anti fungal as research |
814 | 1 | 0.01 | qabushaqra@hotmail.com |
815 | 1 | 0.01 | pdf jurnal analgesic from sponge |
816 | 1 | 0.01 | problem of brittle fracture in pharmaceu... |
817 | 1 | 0.01 | terminalia glaucescens .pdf |
818 | 1 | 0.01 | tramadol 200 mg formulation ,which one u... |
819 | 1 | 0.01 | extract and anticonvulsant |
820 | 1 | 0.01 | &si=d2dnewnewid |
821 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
822 | 1 | 0.01 | organisms present in okpa |
823 | 1 | 0.01 | pharmaceutical care benefits |
824 | 1 | 0.01 | serum c3 |
825 | 1 | 0.01 | staphylococcus among nigeria women |
826 | 1 | 0.01 | hydrophobicity excipients |
827 | 1 | 0.01 | cardiac manifestations of snake bite in ... |
828 | 1 | 0.01 | faezeh ghanati 2014 |
829 | 1 | 0.01 | formulation and characterization of mimi... |
830 | 1 | 0.01 | chemical penetration enhancers |
831 | 1 | 0.01 | phytochemical of the leaves of picralima... |
832 | 1 | 0.01 | pharmceutical manufacturing process vali... |
833 | 1 | 0.01 | http://www.tjpr.org/vol8_no2/2009_8_2_11... |
834 | 1 | 0.01 | microsphere prepration |
835 | 1 | 0.01 | microspheres pdf |
836 | 1 | 0.01 | process development pharmaceutical labor... |
837 | 1 | 0.01 | http://www.tjpr.org/vol6_no4/646sapkal.p... |
838 | 1 | 0.01 | the role of a community pharmacist in th... |
839 | 1 | 0.01 | synthesis+antimicrobial+pdf |
840 | 1 | 0.01 | tjpr?q=tjpr |
841 | 1 | 0.01 | validation pdf in pharmacy |
842 | 1 | 0.01 | nano technology in droug |
843 | 1 | 0.01 | akmal djamaan |
844 | 1 | 0.01 | "cancer cell" line plant |
845 | 1 | 0.01 | analytical method for meloxicam |
846 | 1 | 0.01 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
847 | 1 | 0.01 | mucin drug |
848 | 1 | 0.01 | journal of pharmaceutical research |
849 | 1 | 0.01 | equation between chloroquine phosphate a... |
850 | 1 | 0.01 | patient satisfaction and time delays |
851 | 1 | 0.01 | non fickian diffusion based release of d... |
852 | 1 | 0.01 | what is witepsol? pdf |
853 | 1 | 0.01 | "87-901a" durotak |
854 | 1 | 0.01 | low c3 and c4 differential diagnosis |
855 | 1 | 0.01 | i~n~d~i~a~%~2~0~c~e~f~u~r~o~x~i~m~e~%~2~... |
856 | 1 | 0.01 | journal of pharmacy research |
857 | 1 | 0.01 | determination of antimicrobial zone of i... |
858 | 1 | 0.01 | reserpine uv absorbance |
859 | 1 | 0.01 | method development using uv-vis in pharm... |
860 | 1 | 0.01 | nutrient agar contamination and folic ac... |
861 | 1 | 0.01 | what are c4 levels with lupus |
862 | 1 | 0.01 | abbas azadmehr |
863 | 1 | 0.01 | attitude and behavior toward clinical ph... |
864 | 1 | 0.01 | antipyretic activity pdf |
865 | 1 | 0.01 | tropical journals |
866 | 1 | 0.01 | taha jiangnan |
867 | 1 | 0.01 | pyridostigmine bromide tablets direct co... |
868 | 1 | 0.01 | tropical j pharmaceutical research |
869 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
870 | 1 | 0.01 | formulation and evaluation of microspher... |
871 | 1 | 0.01 | antiacterial activity of some toothpaste... |
872 | 1 | 0.01 | beta cyclodextrin pdf |
873 | 1 | 0.01 | hplc simultaneous determination tcm |
874 | 1 | 0.01 | pharmaceutical research journal springer |
875 | 1 | 0.01 | product to product cleaning procedure in... |
876 | 1 | 0.01 | http://www.tjpr.org/ |
877 | 1 | 0.01 | good dispensing practice pdf |
878 | 1 | 0.01 | embryonic-stem-cell-test |
879 | 1 | 0.01 | cellulose british pharmacopoeia 2004 |
880 | 1 | 0.01 | complement c3 c4 kidney disease |
881 | 1 | 0.01 | differential scanning calorimetry |
882 | 1 | 0.01 | imeokparia and offor, 1992 |
883 | 1 | 0.01 | http://www.tjpr.org/jmanager/manuscript/... |
884 | 1 | 0.01 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
885 | 1 | 0.01 | who, atherosclerosis in nigeria |
886 | 1 | 0.01 | multiparticulate drug formulations |
887 | 1 | 0.01 | department of pharmaceutical chemistry, ... |
888 | 1 | 0.01 | 2) miyazaki k, islam n. nanotechnology s... |
889 | 1 | 0.01 | tropical journal of pharmaceutical scien... |
890 | 1 | 0.01 | اتیل استات pdf |
891 | 1 | 0.01 | pull and push drug supply |
892 | 1 | 0.01 | in tramadol formulation why use carbopol |
893 | 1 | 0.01 | the royal society and the royal academy ... |
894 | 1 | 0.01 | tropical journal of pharmaceutical resea... |
895 | 1 | 0.01 | are aloe vera can prepare tablet |
896 | 1 | 0.01 | ana profile c3 and c4 |
897 | 1 | 0.01 | sodium starch glycolate ir spectra with ... |
898 | 1 | 0.01 | curcumin microsponge gastroretentive tab... |
899 | 1 | 0.01 | ciprofloxacin therapeutic effects in tre... |
900 | 1 | 0.01 | http://www.tjpr.org/vol11_no6/index.php |
901 | 1 | 0.01 | recent trends on ethnobotanical studiesp... |
902 | 1 | 0.01 | review artical of saraca asoka |
903 | 1 | 0.01 | microballoon review article pdf |
904 | 1 | 0.01 | low c3 and c4 |
905 | 1 | 0.01 | pharmaceutical process validation pdf |
906 | 1 | 0.01 | complement level glomerulonephritis tabl... |
907 | 1 | 0.01 | cache:http://www.tjpr.org/vol7_no2/7210p... |
908 | 1 | 0.01 | pdf file amin a f emerging trends in ora... |
909 | 1 | 0.01 | pharmaceutical care stroke patients |
910 | 1 | 0.01 | tropical journal of pharmaceutical rese... |
911 | 1 | 0.01 | tahir khan monash |
912 | 1 | 0.01 | tests for flavonoids |
913 | 1 | 0.01 | obialunamma onoh |
914 | 1 | 0.01 | suppositories pdf |
915 | 1 | 0.01 | coacervation with na alginate and cacl |
916 | 1 | 0.01 | calculate alginate molecular weight from... |
917 | 1 | 0.01 | glycoprotein polysaccharide cancer |
918 | 1 | 0.01 | ethno botany, pdf |
919 | 1 | 0.01 | journal of current pharmaceutical resear... |
920 | 1 | 0.01 | in vitro dialysis studies of amphoterici... |
921 | 1 | 0.01 | http://www.tjpr.org/vol13_no5/2014_13_5_... |
922 | 1 | 0.01 | complement c3 c4 normal range |
923 | 1 | 0.01 | drug delivery enhnacer |
924 | 1 | 0.01 | trop j of phar res |
925 | 1 | 0.01 | orally disintegrating tablets a review |
926 | 1 | 0.01 | low c3 nephritis differential |
927 | 1 | 0.01 | names of international journals pf phar... |
928 | 1 | 0.01 | anti jundice activity of arborinine alka... |
929 | 1 | 0.01 | drug delivery technology skin |
930 | 1 | 0.01 | determination of dissolution sink condit... |
931 | 1 | 0.01 | complex 2 inhibitor assay |
932 | 1 | 0.01 | uba letterhead |
933 | 1 | 0.01 | articles on controlled release tablets o... |
934 | 1 | 0.01 | association between serum levels of c3 a... |
935 | 1 | 0.01 | potentially inappropriate medication in ... |
936 | 1 | 0.01 | multiparticulate system |
937 | 1 | 0.01 | in vitro antibacterial activities of cru... |
938 | 1 | 0.01 | journal of ethnobotany in nigeria |
939 | 1 | 0.01 | preparation and evaluation of microsphe... |
940 | 1 | 0.01 | liver cancer galactose |
941 | 1 | 0.01 | http://www.tjpr.org/vol10_no2/2011_10_2_... |
942 | 1 | 0.01 | bromocresol purple for determine alkaloi... |
943 | 1 | 0.01 | activity antimicrobial filetype:pdf |
944 | 1 | 0.01 | benefits of green tea pdf |
945 | 1 | 0.01 | prescription pattern and cost analysis i... |
946 | 1 | 0.01 | manasamitra vatakam |
947 | 1 | 0.01 | bazeka saxe dowalond |
948 | 1 | 0.01 | abu shaqra cosmatic factory |
949 | 1 | 0.01 | faculty of traditional thai medicine and... |
950 | 1 | 0.01 | http://www.tjpr.org/vol13_no4/2014_13_4_... |
951 | 1 | 0.01 | methods of preparation of microcapsules |
952 | 1 | 0.01 | comparison of uti in male and female res... |
953 | 1 | 0.01 | journal of chemical & pharmaceutical sci... |
954 | 1 | 0.01 | "tacca plantaginea" cancer |
955 | 1 | 0.01 | challenges and herbal medicine graduate |
956 | 1 | 0.01 | thiolated chitosans: novel polymers for ... |
957 | 1 | 0.01 | tjpr current issue |
958 | 1 | 0.01 | titilayo rasaq |
959 | 1 | 0.01 | what is evaluation objective of primary ... |
960 | 1 | 0.01 | high c3 and c4 |
961 | 1 | 0.01 | wat is d max alcohol blood level for dri... |
962 | 1 | 0.01 | umachigi 2008 quercus pdf |
963 | 1 | 0.01 | tfr binding peptide |
964 | 1 | 0.01 | tjpr.org |
965 | 1 | 0.01 | review article on dosage - forms design,... |
966 | 1 | 0.01 | r parameters for cutometer |
967 | 1 | 0.01 | stability indicating analytical method f... |
968 | 1 | 0.01 | statistical significance n waiting time ... |
969 | 1 | 0.01 | how to use priprobit |
970 | 1 | 0.01 | flavonoids most commonly used as antibac... |
971 | 1 | 0.01 | anticonvulsant activity of plant extract... |
972 | 1 | 0.01 | c3c e c4 |
973 | 1 | 0.01 | pharma validation sampling systems |
974 | 1 | 0.01 | pharmaceutical validation online certifi... |
975 | 1 | 0.01 | skin absorption enhancers |
976 | 1 | 0.01 | validation and verification in pharma |
977 | 1 | 0.01 | trop j pharm re\x03=1684 |
978 | 1 | 0.01 | sample questionnaire on substance abuse ... |
979 | 1 | 0.01 | significant alteration drug manufacture ... |
980 | 1 | 0.01 | pdf clarence between the punch and matri... |
981 | 1 | 0.01 | nanoparticle in rat |
982 | 1 | 0.01 | plant extracts as analgesics pdf 2014 |
983 | 1 | 0.01 | hplc analysis of reserpine |
984 | 1 | 0.01 | foster journal of pharmacy research |
985 | 1 | 0.01 | elevated c3 and c4 levels in amyloidosis |
986 | 1 | 0.01 | low c3 complement and ana 1:160 normal c... |
987 | 1 | 0.01 | microspheres on metronidazol and diclofe... |
988 | 1 | 0.01 | hydration capacity of mcc |
989 | 1 | 0.01 | identification of essential oil componen... |
990 | 1 | 0.01 | key(marigold antioxidant) |
991 | 1 | 0.01 | what is requalification in pharama |
992 | 1 | 0.01 | time-release drugs and nacl solution how... |
993 | 1 | 0.01 | antioxidative and hepatoprotective activ... |
994 | 1 | 0.01 | boswellia serrata formulations |
995 | 1 | 0.01 | corynebacterium glutamicum aspartokinase |
996 | 1 | 0.01 | important back titration method of assay... |
997 | 1 | 0.01 | chemical penetration enhancers |
998 | 1 | 0.01 | all about terminalia glauceseus |
999 | 1 | 0.01 | perscription waiting time |
1000 | 1 | 0.01 | http://www.tjpr.org/vol11_no3/2012_11_3_... |
1001 | 1 | 0.01 | transdermal patch using eugenol as penet... |
1002 | 1 | 0.01 | chimechal contents of stevia leaf pdf 20... |
1003 | 1 | 0.01 | chemical permeation enhancer |
1004 | 1 | 0.01 | block copolymer micelle applications |
1005 | 1 | 0.01 | chitosan+avearage molucular weight |
1006 | 1 | 0.01 | gender age urinary tract infections |
1007 | 1 | 0.01 | use of plant extract for genotoxicity |
1008 | 1 | 0.01 | transdermal, drug penetration enhancer |
1009 | 1 | 0.01 | recurrent brucellosis treatment |
1010 | 1 | 0.01 | microsphere formulation |
1011 | 1 | 0.01 | isolation and identification of escheric... |
1012 | 1 | 0.01 | php web development company lviv?q=php w... |
1013 | 1 | 0.01 | cxcr4 antagonist |
1014 | 1 | 0.01 | assay of chloroquine phosphate using sod... |
1015 | 1 | 0.01 | uti pathogens research |
1016 | 1 | 0.01 | antimicrobial activity of raw extracts o... |
1017 | 1 | 0.01 | effect of nano-silver and silver nitrate... |
1018 | 1 | 0.01 | http://www.tjpr.org/vol13_no4/2014_13_4_... |